<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04438330</url>
  </required_header>
  <id_info>
    <org_study_id>H-19080328</org_study_id>
    <nct_id>NCT04438330</nct_id>
  </id_info>
  <brief_title>The Immunological Profile of Nickel Dermatitis</brief_title>
  <official_title>The Immunological Profile of Nickel Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Allergy Research Center, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Allergy Research Center, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A dose-response study on the immune phenotype of allergic nickel dermatitis on a previously
      exposed skin area.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinically controlled study comprising 15 people with known nickel allergy and 15 healthy
      persons as control group. At the Department of Allergy and Dermatology, Gentofte Hospital,
      test participants will be exposed to nickel sulfate in a patch test on their back, which will
      create an eczema reaction in people with nickel allergy and induce skin resident T-cells. The
      resident T-cells will enhance further exposure. The eczema is healed over 3-4 weeks, after
      which the same areas are again exposed to nickel sulfate at different concentrations in a
      patch test. Skin biopsies of the exposed areas are taken and the immune phenotype is analyzed
      trough Nanostring RNA technologies of around 600 immunerelated genes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mRNA Nanostring screening</measure>
    <time_frame>1 month</time_frame>
    <description>Screening of 600 immune-related genes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Protein verification</measure>
    <time_frame>2 month</time_frame>
    <description>verification of differentially regulated mRNA at a protein level.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Allergic response</measure>
    <time_frame>1 day</time_frame>
    <description>Clinical evaluation of allergic response to a dose-range</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Nickel; Eczema</condition>
  <condition>Nickel Sensitivity</condition>
  <condition>Allergy</condition>
  <condition>Inflammatory Response</condition>
  <arm_group>
    <arm_group_label>Nickel allergic individuals</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nickel sulfate hexahydrate in petrolatum. Exposed in a patch test dose-range with a max concentration of 5% nickel sulfate hexahydrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-nickel allergic individuals</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nickel sulfate hexahydrate in petrolatum. Exposed in a patch test dose-range with a max concentration of 5% nickel sulfate hexahydrate</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nickel sulfate hexahydrate</intervention_name>
    <description>Patch test</description>
    <arm_group_label>Nickel allergic individuals</arm_group_label>
    <arm_group_label>non-nickel allergic individuals</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        inclusion criteria

          -  Must be able to understand the written and oral participant information in Danish.

          -  Previously proven nick allergy by patch testing within the last 5 years, for the
             nickel allergic test participants.

        exclusion criteria

          -  Pregnancy and / or breastfeeding.

          -  Systemic immunomodulatory treatments within the last 14 days.

          -  Local treatments of selected skin areas, such as applying hormone cream within the
             last two weeks or applying cream / lotion within 24 hours up to sample collection.

          -  Allergy to local anesthesia.

          -  Exposed to solar or sunlight on the back within 21 days.

          -  History of inflammatory skin diseases, asthma, Diabetes Mellitus, hives or arthritis
             (exclusion criteria only for participation in the healthy control group).

          -  Participation in another scientific experiment within the last 4 weeks. risks,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeanne D Johansen, Proff.</last_name>
    <role>Study Director</role>
    <affiliation>National Allergy Research Center, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Wennervaldt, Cand.scient</last_name>
    <phone>004538674157</phone>
    <email>michael.wennervaldt.joergensen@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Allergy Research Center</name>
      <address>
        <city>Hellerup</city>
        <state>Danmark</state>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <contact>
      <last_name>Michael Wennervaldt, cand.scient</last_name>
      <phone>38677300</phone>
      <email>mwennervaldt@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 16, 2020</study_first_submitted>
  <study_first_submitted_qc>June 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2020</study_first_posted>
  <last_update_submitted>June 18, 2020</last_update_submitted>
  <last_update_submitted_qc>June 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Patch test</keyword>
  <keyword>metal allergy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nickel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

